Genitourinary Disorders :
Explore Genetic Insights
Summary
Diseases Found | 46 |
High Risk | 1 |
Medium Risk | 43 |
Low Risk | 2 |
Mutated Genes Found | 21 |
Contents
- Autoimmune Disorders Page 1
- Brain Health (Neurological Disorders) Page 2
- Cancers (Neoplastic Diseases) Page 3
- Dermatological Diseases Page 4
- Endocrine Disorders Page 5
- Gastrointestinal Disorders Page 6
- Genitourinary Disorders Page 7
- Heart Health (Cardiovascular Diseases) Page 8
- Hematological Disorders Page 9
- Metabolic Disorders Page 10
- Musculoskeletal Diseases Page 11
- Obstetric and Gynecological Disorders Page 12
- Ophthalmological Diseases Page 13
- Appendix
Genitourinary Disorders :
The following diseases are associated with Genitourinary Disorders ::
Disease | Predisposition |
---|---|
Male Urogenital Diseases | Medium |
Male Urogenital Diseases
Periodontal disease does not follow a specific pattern of genetic transmission. However, genetic factors may contribute to an individual's susceptibility to the disease, interacting with environmental and behavioral factors such as oral hygiene and smoking.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
ANK2 | Insertion | A/A | Medium |
FOXD4 | Deletion | T/A | Medium |
ZNF518B | Deletion | G/T | High |
GSTM4 | Insertion | G/A | High |
MRPL36 | Frameshift | T/C | Medium |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
ANK2 | 24% |
FOXD4 | 25% |
ZNF518B | 2% |
GSTM4 | 14% |
MRPL36 | 5% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-74160 | mTOR Signaling Pathway | Involved in cell growth and survival |
REACT:R-HSA-1430728 | Dopaminergic Signaling | Regulates neurotransmitter release |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
ANK2 | Stroke | Genetic predisposition |
FOXD4 | Hypertension | Genetic predisposition |
ZNF518B | Stroke | Genetic predisposition |
GSTM4 | Asthma | Chronic infection |
MRPL36 | Cancer | Cellular apoptosis |
Recommendations for Medium Risk for Periodontal Disease
- Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
- Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
- Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
- Personalized Lifestyle Plan:
- Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
- Engage in regular physical activity, such as walking, swimming, or light strength training.
- Incorporate stress management techniques like deep breathing exercises or light yoga.
- Limit alcohol consumption and reduce exposure to pollutants.
For additional guidance on managing your predisposition: See treatment options for Male Urogenital Diseases.
Appendix
Mutated Genes Found
Gene | Associated Diseases | Chromosome Position |
---|---|---|
SLC12A7 |
|
Chr4:73744739 |
ANK2 |
|
Chr14:37863127 |
ZFYVE9 |
|
ChrY:17861272 |
FOXD4 |
|
Chr6:13090099 |
ACAD9-DT |
|
Chr7:86272676 |
PUM3 |
|
Chr16:30017889 |
MRPL36 |
|
Chr20:68124422 |
GSTM4 |
|
Chr8:17818001 |
TMEM45A |
|
Chr12:63530859 |
ZDHHC11 |
|
ChrY:70691281 |
ZNF518B |
|
Chr13:28556476 |
GTPBP8 |
|
Chr18:21179082 |
PHACTR2 |
|
Chr13:33804828 |
MROH2B |
|
Chr20:61695250 |
GRM6 |
|
Chr7:22659683 |
NQO2 |
|
Chr1:22186589 |
SDHA |
|
Chr8:55004154 |
ACAD9 |
|
Chr9:37223481 |
LRPPRC |
|
Chr9:89811902 |
ACTN2 |
|
Chr15:32463007 |
FAM110C |
|
Chr10:62269223 |
Diseases Found
Disease | Category | Predisposition |
---|---|---|
immune system diseases | Autoimmune Disorders : | Medium |
Autoimmune Diseases | Autoimmune Disorders : | Medium |
Connective Tissue Diseases | Autoimmune Disorders : | Low |
demyelinating autoimmune diseases, cns | Autoimmune Disorders : | Low |
Alzheimer Disease | Brain Health (Neurological Disorders) | High |
Nervous System Diseases | Brain Health (Neurological Disorders) | Medium |
Neurodegenerative Diseases | Brain Health (Neurological Disorders) | Medium |
Cerebrovascular Disorders | Brain Health (Neurological Disorders) | Medium |
central nervous system diseases | Brain Health (Neurological Disorders) | Medium |
brain diseases, metabolic | Brain Health (Neurological Disorders) | Medium |
neuromuscular diseases | Brain Health (Neurological Disorders) | Medium |
lysosomal storage diseases, nervous system | Brain Health (Neurological Disorders) | Medium |
neurologic manifestations | Brain Health (Neurological Disorders) | Medium |
cranial nerve diseases | Brain Health (Neurological Disorders) | Medium |
Spinal Cord Ischemia | Brain Health (Neurological Disorders) | Medium |
genital neoplasms, male | Cancers (Neoplastic Diseases) | Medium |
Prostatic Neoplasms | Cancers (Neoplastic Diseases) | Medium |
Breast Neoplasms | Cancers (Neoplastic Diseases) | Medium |
Gastrointestinal Neoplasms | Cancers (Neoplastic Diseases) | Medium |
Digestive System Neoplasms | Cancers (Neoplastic Diseases) | Medium |
skin and connective tissue diseases | Dermatological Diseases : | Medium |
Endocrine System Diseases | Endocrine Disorders : | Medium |
digestive system diseases | Gastrointestinal Disorders : | Medium |
Gastrointestinal Diseases | Gastrointestinal Disorders : | Medium |
Intestinal Diseases | Gastrointestinal Disorders : | Medium |
Male Urogenital Diseases | Genitourinary Disorders : | Medium |
Cardiovascular Abnormalities | Heart Health (Cardiovascular Diseases) | Medium |
Cardiomyopathy, Hypertrophic | Heart Health (Cardiovascular Diseases) | Medium |
Vascular Diseases | Heart Health (Cardiovascular Diseases) | Medium |
Hypertension | Heart Health (Cardiovascular Diseases) | Medium |
Coronary Artery Disease | Heart Health (Cardiovascular Diseases) | Medium |
hemic and lymphatic diseases | Hematological Disorders : | Medium |
Hematologic Diseases | Hematological Disorders : | Medium |
Blood Coagulation Disorders | Hematological Disorders : | Medium |
Hemorrhagic Disorders | Hematological Disorders : | Medium |
Thrombophilia | Hematological Disorders : | Medium |
carbohydrate metabolism, inborn errors | Metabolic Disorders : | Medium |
lipid metabolism disorders | Metabolic Disorders : | Medium |
lipidoses | Metabolic Disorders : | Medium |
Obesity | Metabolic Disorders : | Medium |
Diabetes Mellitus, Type 1 | Metabolic Disorders : | Medium |
Lipid Metabolism, Inborn Errors | Metabolic Disorders : | Medium |
musculoskeletal diseases | Musculoskeletal Diseases : | Medium |
Muscular Diseases | Musculoskeletal Diseases : | Medium |
female urogenital diseases and pregnancy complications | Obstetric and Gynecological Disorders : | Medium |
female urogenital diseases and pregnancy complications | Ophthalmological Diseases : | Medium |